Cargando…
What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
BACKGROUND: Drug-resistant tuberculosis (DR-TB) is undermining TB control in South Africa. However, there are hardly any data about the cost of treating DR-TB in high burden settings despite such information being quintessential for the rational planning and allocation of resources by policy-makers,...
Autores principales: | Pooran, Anil, Pieterson, Elize, Davids, Malika, Theron, Grant, Dheda, Keertan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548831/ https://www.ncbi.nlm.nih.gov/pubmed/23349933 http://dx.doi.org/10.1371/journal.pone.0054587 |
Ejemplares similares
-
Diagnosis of COVID-19: Considerations, Controversies and Challenges in South Africa
por: Dheda, Keertan, et al.
Publicado: (2020) -
Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013) -
The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report
por: Davids, Malika, et al.
Publicado: (2021) -
Correction: Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa
por: Shean, Karen, et al.
Publicado: (2013) -
The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor
por: Tomasicchio, Michele, et al.
Publicado: (2019)